Purchase Order 75N94019P00910

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to SPT Labtech LIMITED for $21,960.00 on September 9, 2019. Performance is located in Great Britain, United Kingdom. The order procures advanced laboratory automation solutions and associated equipment from the manufacturer. The purchase order is firm fixed price with no small business set-aside. Ultimate completion date is September 24, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,890.00 on May 28, 2014, with completion due June 2, 2014. The order is firm fixed price with no set-aside designation. Work is performed in Beverly, Massachusetts. The source does not specify the goods or services being procured.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $8,361.40 on April 1, 2015. Work is performed in Bethesda, Maryland. The order was issued with no set-aside designation and carries a firm fixed-price structure. Ultimate completion is scheduled for April 10, 2015.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Thermo Electron North America LLC for $11,578.02 on May 31, 2019. The order, classified as a firm fixed-price purchase order with no set-aside designation, obligated funds for scientific instrumentation or laboratory equipment support. Work is performed in Bethesda, Maryland. The order's ultimate completion date was June 4, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to LGC Genomics LLC for $10,379.38, with an award date of September 24, 2013 and completion by September 30, 2013. Work is performed in Beverly, Massachusetts. No set-aside applies. The order is priced on a firm fixed-price basis. Specific scope details are not provided in the source material.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $37,343.66 delivery order to Illumina, Inc. on July 10, 2026.</p> <p>Place of performance is Bethesda, MD 20892. No set-aside was used for this order. The order is priced on a firm fixed-price basis with an ultimate completion date of July 10, 2026.</p>